Treatment for women with postpartum iron deficiency anaemia

Cochrane Database of Systematic Reviews

Volumn 2004, Issue 4, 2004, Pages

  Dodd, Jodie M ^a   Dare, Marianna R ^b   Middleton, Philippa ^b   Kellie, Frances J ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IRON;

BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; META ANALYSIS; PUERPERAL DISORDER; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANEMIA, IRON-DEFICIENCY; ERYTHROPOIETIN; FEMALE; HUMANS; IRON; PUERPERAL DISORDERS; RANDOMIZED CONTROLLED TRIALS;

EID: 16644382240     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004222.pub2     Document Type: Review

References (68)

1. Breymann C, Zimmermann R, Huch R, Huch A. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. European Journal of Clinical Investigation 1996;26:123-30.
2. Krafft A, Breymann C, Huttner C, Huch R, Huch A. Erythropoietic quality of maternal milk. Lancet 1999;354(9180):778.
3. Breymann C, Richter C, Huttner C, Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. European Journal of Clinical Investigation 2000;30:154-61.
4. Lebrecht A, Haberlin F, Eberhard J. Anemia in puerperium: parenteral iron substitution renders erythropoietin therapy dispensable [Anamie im Wochenbett: parenterale Eisensubstitution macht Erythropoetin-Therapie entbehrlich]. Geburtshilfe und Frauenheilkunde 1995;55(3):167-70.
5. Makrydimas G, Lolis D, Lialios G, Tsiara S, Georgiou I, Bourantas K. Recombinant human erythropoietin treatment of postpartum anaemia, preliminary results. European Journal of Obstetrics & Gynecology and Reproductive Biology 1998;81:27-31.
6. Meyer J, Eichhorn K, Vetter K, Christen S, Schleusner E, Klos A, et al. Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well?. Journal of Perinatal Medicine 1995;23:99-109.
7. Zimmermann R, Breymann C, Huch R, Huch A. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration. Clinical Investigation 1994;72(6 Suppl):S25-30.
8. Casparis D, Del Carlo P, Branconi F, Grossi A, Merante D, Gafforio L. Effectiveness and tolerance of oral doses of liquid ferrous gluconate in iron deficiency anaemia during pregnancy and in the immediate post-natal period: comparisons with other liquid or solid formulations containing bivalent or trivalent iron. Minerva Ginecologica 1996;48:511-8.
9. Danko J, Huch R, Huch A. Epoetin alfa for treatment of postpartum anaemia. Lancet 1990;335:737-8.
10. Huch A, Eichhorn K, Danko J, Lauener P, Huch R. Recombinant human erythropoietin in the treatment of postpartum anemia. Obstetrics & Gynecology 1992;80:127-31.
11. Mara M, Zivny J, Eretova V, Kvasnicka J, Kuzel D, Umlaufova A, et al. Changes in markers of anemia and iron metabolism and how they are influenced by antianemics in postpartum period. Acta Obstetrica Gynecologica Scandinavica 2001;80:142-8.
12. Osmond TG. Post-partum anaemia, a practical treatment. Practitioner 1953;171:77-80.
13. Picha E. A new direction for iron therapy [Ein neuer Weg der Eisentherapie]. Geburtshilfe und Frauenheilkunde 1975;35(10):792-5.
14. Zimmermann R, Breymann C, Richter C, Huch R, Huch A. rhEPO treatment of postpartum anaemia. Journal of Perinatal Medicine 1995;23:111-7.
15. Backe B. A 6-week randomised, open comparative, multi-centre study of intravenous ferric carboxymaltose (ferinject) and oral iron (duroferon) for treatment of post partum anemia. http://clinicaltrials.gov/ct2/show/record/NCT00929409 (accessed 5 June 2012) 2009.
16. Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. Journal of Nutrition 2005;135(2):267-72.
17. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. International Journal of Obstetric Anesthesia 2004;13(3):S7.
18. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG: an International Journal of Obstetrics and Gynaecology 2006;113(11):1248-52.
19. Breymann C, von Seefried B, Stahel M, Geisser P, Canclini C. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. Journal of Perinatal Medicine 2007;35(2):115-8.
20. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International Journal of Gynecology & Obstetrics 2008;101(1):67-73.
21. Daniilidis A, Giannoulis C, Pantelis A, Tantanasis T, Dinas K. Total infusion of low molecular weight iron-dextran for treating postpartum anemia. Clinical and Experimental Obstetrics and Gynecology 2011;38(2):159-61.
22. Dede A, Uygur D, Yilmaz B, Mungan T, Ugur M. Intravenous iron sucrose complex vs. oral ferrous sulfate for postpartum iron deficiency anemia. International Journal of Gynecology & Obstetrics 2005;90(3):238-9.
23. Haidar J, Umeta M, Kogi-Makau W. Effect of iron supplementation on serum zinc status of lactating women in Addis Ababa, Ethiopia. East African Medical Journal 2005;82(7):349-52.
24. Hashmi Z, Bashir G, Azeem P, Shah S. Effectiveness of intra-venous iron sucrose complex versus intra-muscular iron sorbitol in iron deficiency anemia. Annals of Pakistan Institute of Medical Sciences 2006;2(3):188-91.
25. Huch A, Huch R. EPO (rHuEPO) use in obstetrics. Proceedings of Ross Laboratories Special Conference, Hot Topics '90 in Neonatology; 1990 Dec 9-11; Washington DC, USA. 1990:79-80.
26. Jansen AJG, Duvekot JJ, Essink-Bot ML, Hop WCJ, Van Rhenen DJ. Multicentre clinical study into the optimal blood transfusion policy in patients with postpartum haemorrhage: The 'Wellbeing of obstetric patients on minimal blood transfusions' (WOMB) study [Een klinisch multicentrisch onderzoek naar het optimale bloedtransfusiebeleid bij patienten met een fluxus post partum: De 'Wellbeing of obstetric patients on minimal blood transfusions'(WOMB)-studie]. Nederlands Tijdschrift voor Geneeskunde 2007;151(39):2170-2.
27. Krafft A, Breymann C. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. Journal of Obstetrics and Gynaecology Research 2011;37(2):119-24.
28. Krauss V, Nowotny D, Scharifzadeh AH. Effect and tolerance of oral iron therapy in the puerperium. Munchener Medizinische Wochenschrift 1972;114(43):1877-9.
29. Mara M, Eretova V, Zivny J, Kvasnicka J, Umlaufova A, Marova E. Anemia and its treatment with peroral anti-anemia agents in women during the postpartum period. [Czech]. Ceska Gynekologie 1999;64:153-8.
30. Murray-Kolb LE, Beard JL. Iron deficiency and child and maternal health. American Journal of Clinical Nutrition 2009;89(3):946S-50S.
31. Palacio M. Intravenous iron versus oral iron for severe postpartum anemia randomized trial. http://clinicaltrials.gov/ct2/show/record/NCT00660933 (accessed 5 June 2012) 2007.
32. Perez EM, Hendricks MK, Beard JL, Murray-Kolb LE, Berg A, Tomlinson M, et al. Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. Journal of Nutrition 2005;135(4):850-5.
33. Prick BW, Steegers EAP, Jansen AG, Hop WCJ, Essink-Bot M-L, Peters NCJ, et al. Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy and Childbirth 2010;10:83.
34. Prick BW, Jansen AJG, Steegers EAP, Hop WCJ, Essink-Bot ML, Uyl-de Groot CA, et al. RBC transfusion leads to an improvement of physical fatigue in women with acute postpartum anemia: the WOMB study (NCT00335023). American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S41-2.
35. Seid MH, Rogers R, Dinh Q. Treating postpartum anemia with intravenous ferric carboxymaltose in a randomized controlled study. American Journal of Obstetrics and Gynecology 2007;197(6 Suppl 1):S26, Abstract no: 55.
36. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 2008;199(4):435.e-1-435.e7.
37. Tam KF, Lee CP, Pun TC. Mild postnatal anemia: is it a problem?. American Journal of Perinatology 2005;22(7):345-9.
38. Van der Woude D. Iron and folic acid v.s. iron solely in the treatment of post partum anaemia; effects on haemoglobin and health status. Netherlands Trial Register (http://www.trialregister.nl) (accessed 8 July 2011) 2011.
39. Van Rhenen DJ. Wellbeing of obstetric patients on minimal bloodtranfusions study - WOMB study. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005)) 2005.
40. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstetrics & Gynecology 2007;110(2 Pt 1):267-78.
41. Verma S, Inamdar SA, Malhotra N. Intravenous iron therapy versus oral iron in postpartum patients in rural area. Journal of SAFOG 2011;3(2):67-70.
42. Wagstrom E, Akesson A, Van Rooijen M, Larson B, Bremme K. Erythropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstetricia et Gynecologica Scandinavica 2007;86(8):957-62.
43. Westad S, Backe B, Salvesen KA, Nakling J, Okland I, Borthen I, et al. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstetricia et Gynecologica Scandinavica 2008;87(9):916-23.
44. Westad S, Backe B, Salvesen K, Nakling J, Okland I, Borthen I, et al. A 12-week randomised, multi-centre study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anaemia. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S377.
45. Epoetin alfa and pure red cell aplasia. Australian Adverse Drug Reactions Bulletin; www.health.gov.au/tga/adr/aadrd/aadr0208.htm [accessed 16 December 2003] August 2002.
46. Atkinson L, Baxley E. Post partum fatigue. American Family Physician 1994;50(1):113-8.
47. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian J-J, Martin-Dupont P, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. New England Journal of Medicine 2002;346(7):469-75.
48. Clarke M, Oxman A, editors. Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]. Review Manager (RevMan) [computer program]. Oxford, UK: The Cochrane Collaboration, 2003.
49. Davis HP. Erythropoietin for patient refusing blood transfusion. Lancet 1990;336:384-5.
50. Dudrick S, O'Donnell J, Matheny R, Unkel S, Raleigh D. Stimulation of hematopoiesis as an alternative to transfusion. Southern Medical Journal 1986;79(6):669-73.
51. Ekanem A, Etuk S, Samson-Akpan U. The influence of cultural practice on puerperal anemia. International Journal of Gynecology & Obstetrics 1996;55:169-70.
52. Gibbs R. Clinical risk factors for puerperal infection. Obstetrics & Gynecology 1980;55(5 Suppl):178S-84S.
53. Gilbert L, Porter W, Brown VA. Postpartum haemorrhage - a continuing problem. British Journal of Obstetrics and Gynaecology 1987;94:67-71.
54. Harrison K. Maternal mortality in developing countries. British Journal of Obstetrics and Gynaecology 1989;96:1-3.
55. Klapholz H. Blood transfusion in contemporary obstetric practice. Obstetrics & Gynecology 1990;75(6):940-3.
56. Kumar R, Sharma A, Barik S, Kumar V. Maternal mortality inquiry in a rural community of North India. International Journal of Gynecology & Obstetrics 1989;29:313-9.
57. Mahomed K. Iron supplementation in pregnancy (Cochrane Review). The Cochrane Library 2003, Issue 4.
58. Markova V, Norgaard A, Jørgensen KJ, Langhoff-Roos J. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database of Systematic Reviews 2015, Issue 8. [DOI: 10.1002/14651858.CD010861.pub2]
59. Naef R, Washburne J, Martin R, Magann E, Scanlon P, Morrison J. Hemorrhage associated with cesarean delivery: when is transfusion needed. Journal of Perinatology 1995;15(1):32-5.
60. Naef R, Morrison J. Transfusion therapy in pregnancy. Clinical Obstetrics and Gynecology 1995;38(3):547-57.
61. Nolan T, Gallup D. Massive transfusion: a current review. Obstetrical and Gynecological Survey 1991;46(5):289-95.
62. The Cochrane Collaboration. Review Manager (RevMan). 4.2.3. Oxford, UK: The Cochrane Collaboration, 2004.
63. Rosenfield A. Maternal mortality in developing countries - an ongoing but neglected 'epidemic'. JAMA 1989;262(3):376-9.
64. Skolnick A. Transfusion medicine faces time of major 'challenges and changes'. JAMA 1992;268(6):697-700.
65. Vora M, Gruslin A. Erythropoietin in obstetrics. Obstetrical and Gynecological Survey 1998; Vol. 53, issue 8:500-8.
66. Waymack J, Yurt R. The effect of blood transfusions on immune function. Journal of Surgical Research 1990;48:147-53.
67. World Health Organization. Reduction of maternal mortality. A joint WHO/UNFPA/UNICEF/World Bank statement. Geneva: WHO, 1999.
68. World Health Organization, United Nations Children's Fund, United Nations University. Iron deficiency anaemia; Assessment, Prevention and Control; A guide for programme managers. Geneva: World Health Organization, 2001.